RecruitingPhase 1 / Phase 2NCT07599670
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Sponsor: AbbVie
Boulder, CO · +10 more sites
1 recruiting alzheimer's disease studies with a site in Boulder, CO.
Sponsor: AbbVie
Boulder, CO · +10 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.